Aberdeen Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$226M Buy
2,602,657
+27,470
+1% +$2.38M 0.38% 40
2025
Q1
$229M Buy
2,575,187
+1,015,174
+65% +$90.4M 0.45% 34
2024
Q4
$124M Buy
1,560,013
+259,725
+20% +$20.6M 0.23% 92
2024
Q3
$116M Sell
1,300,288
-345,521
-21% -$30.9M 0.21% 110
2024
Q2
$130M Sell
1,645,809
-83,039
-5% -$6.54M 0.25% 88
2024
Q1
$151M Buy
1,728,848
+60,889
+4% +$5.31M 0.3% 71
2023
Q4
$137M Buy
1,667,959
+519,270
+45% +$42.8M 0.3% 73
2023
Q3
$90M Buy
1,148,689
+189,884
+20% +$14.9M 0.23% 98
2023
Q2
$84.5M Buy
958,805
+4,172
+0.4% +$368K 0.2% 108
2023
Q1
$77M Sell
954,633
-37,026
-4% -$2.99M 0.19% 113
2022
Q4
$77.1M Buy
991,659
+16,309
+2% +$1.27M 0.21% 107
2022
Q3
$78.8M Buy
975,350
+135,719
+16% +$11M 0.23% 92
2022
Q2
$75.8M Sell
839,631
-43,211
-5% -$3.9M 0.24% 90
2022
Q1
$99.1M Sell
882,842
-222,114
-20% -$24.9M 0.25% 87
2021
Q4
$114M Sell
1,104,956
-1,055,572
-49% -$109M 0.25% 98
2021
Q3
$274M Sell
2,160,528
-322,295
-13% -$40.9M 0.62% 31
2021
Q2
$308M Sell
2,482,823
-146,452
-6% -$18.2M 0.68% 33
2021
Q1
$311M Buy
2,629,275
+201,986
+8% +$23.9M 0.71% 30
2020
Q4
$284M Sell
2,427,289
-49,981
-2% -$5.85M 0.69% 32
2020
Q3
$257M Sell
2,477,270
-31,729
-1% -$3.3M 0.69% 35
2020
Q2
$230M Buy
2,508,999
+58,667
+2% +$5.38M 0.62% 42
2020
Q1
$222M Buy
2,450,332
+419,078
+21% +$37.9M 0.7% 38
2019
Q4
$230M Sell
2,031,254
-6,680
-0.3% -$758K 0.56% 45
2019
Q3
$221M Sell
2,037,934
-237,787
-10% -$25.8M 0.55% 53
2019
Q2
$222M Buy
2,275,721
+1,984
+0.1% +$193K 0.49% 59
2019
Q1
$207M Sell
2,273,737
-1,184,526
-34% -$108M 0.45% 60
2018
Q4
$310M Buy
3,458,263
+322,478
+10% +$28.9M 0.74% 33
2018
Q3
$308M Sell
3,135,785
-106,692
-3% -$10.5M 0.57% 45
2018
Q2
$278M Buy
3,242,477
+269,306
+9% +$23.1M 0.53% 51
2018
Q1
$239M Buy
2,973,171
+41,887
+1% +$3.36M 0.47% 58
2017
Q4
$237M Buy
2,931,284
+23,869
+0.8% +$1.93M 0.45% 63
2017
Q3
$226M Buy
+2,907,415
New +$226M 0.41% 65